Muraro A., Agache I., Clark A., et al.; European Academy of Allergy and Clinical Immunology. EAACI food allergy and anaphylaxis guidelines: Managing patients with food allergy in the community // Allergy. 2014. Vol. 69, N 8. P. 1046–1057. doi: 10.1111/all.12441.
DOI: 10.1111/all.12441
Cardona V., Ansotegui I.J., Ebisawa M., et al. World Allergy Organization anaphylaxis guidance 2020 // World Allergy Organization J. 2020. Vol. 13, N 10. P. 100472. doi: 10.1016/j.waojou.2020.100472.
DOI: 10.1016/j.waojou.2020.100472
Johansson S.G., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use: Report of the nomenclature review committee of the World Allergy Organization, October 2003 // J Allergy Clin Immunol. 2004. Vol. 113, N 5. P. 832–836. doi: 10.1016/j.jaci.2003.12.591.
DOI: 10.1016/j.jaci.2003.12.591
Panesar S.S., Javad S., de Silva D., et al.; EAACI Food Allergy and Anaphylaxis Group. The epidemiology of anaphylaxis in Europe: A systematic review // Allergy. 2013. Vol. 68, N 11. P. 1353–1361. doi: 10.1111/all.12272.
DOI: 10.1111/all.12272
Hanschmann T., Francuzik W., Dölle-Bierke S., et al. Different phenotypes of drug-induced anaphylaxis--Data from the European anaphylaxis registry // Allergy. 2023. Vol. 78, N 6. P. 1615–1627. doi: 10.1111/all.15612.
DOI: 10.1111/all.15612
Chaaban M.R., Warren Z., Baillargeon J.G., et al. Epidemiology and trends of anaphylaxis in the United States, 2004–2016 // Int Forum Allergy Rhinol. 2019. Vol. 9, N 6. P. 607–614. doi: 10.1002/alr.22293.
DOI: 10.1002/alr.22293
Turner P.J., Gowland M.H., Sharma V., et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: An analysis of United Kingdom national anaphylaxis data, 1992–2012 // J Allergy Clin Immunol. 2015. Vol. 135, N 4. P. 956–963.e1. doi: 10.1016/j.jaci.2014.10.
DOI: 10.1016/j.jaci.2014.10
Muraro A., Worm M., Alviani C., et al.; European Academy of Allergy and Clinical Immunology, Food Allergy, Anaphylaxis Guidelines Group. EAACI guidelines: Anaphylaxis (2021 update) // Allergy. 2022. Vol. 77, N 2. P. 357–377. doi: 10.1111/all.15032.
DOI: 10.1111/all.15032
Клинические рекомендации. Анафилактический шок (2-й пересмотр). Российская ассоциация аллергологов и клинических иммунологов; Федерация анестезиологов и реаниматологов, 2023. Режим доступа: https://raaci.ru/dat/pdf/allergic_shock.pdf. Дата обращения: 15.01.2024.https://raaci.ru/dat/pdf/allergic_shock.pdf
Ring J., Messmer K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes // Lancet. 1977. Vol. 1, N 8009. P. 466–469. doi: 10.1016/s0140-6736(77)91953-5.
DOI: 10.1016/s0140-6736(77)91953-5
Bilò M.B., Martini M., Tontini C., et al. Anaphylaxis // Eur Ann Allergy Clin Immunol. 2021. Vol. 53, N 1. P. 4–17. doi: 10.23822/EurAnnACI.1764-1489.158.
DOI: 10.23822/EurAnnACI.1764-1489.158
Peavy R.D., Metcalfe D.D. Understanding the mechanisms of anaphylaxis. // Curr Opinion Allergy Clini Immunol. 2008. Vol. 8, N 4. P. 310–315. doi: 10.1097/ACI.0b013e3283036a90.
DOI: 10.1097/ACI.0b013e3283036a90
Dewachter P., Mouton-Faivre C., Emala C.W. Anaphylaxis and Anesthesia: Controversies and new insights // Anesthesiology. 2009. Vol. 111, N 5. P. 1141–1150. doi: 10.1097/ALN.0b013e3181bbd443.
DOI: 10.1097/ALN.0b013e3181bbd443
Simons F.E., Frew A.J., Ansotegui I.J., et al. Risk assessment in anaphylaxis: Current and future approaches // J Allergy Clin Immunol. 2007. Vol. 120, N 1, Suppl. P. S2–S24. doi: 10.1016/j.jaci.2007.05.001.
DOI: 10.1016/j.jaci.2007.05.001
Smith P.L., Kagey-Sobotka A., Bleecker E.R., et al. Physiologic manifestations of human anaphylaxis // J Clin Investig. 1980. Vol. 66, N 5. P. 1072–1080. doi: 10.1172/JCI109936.
DOI: 10.1172/JCI109936
Khan N.U., Shakeel N., Makda A., et al. Anaphylaxis: Incidence, presentation, causes and outcome in patients in a tertiary-care hospital in Karachi, Pakistan. // QJM. 2013. Vol. 106, N 12. P. 1095–1101. doi: 10.1093/qjmed/hct179.
DOI: 10.1093/qjmed/hct179
Wood R.A., Camargo C.A., Lieberman P., et al. Anaphylaxis in America: The prevalence and characteristics of anaphylaxis in the United States // J Allergy Clin Immunol. 2014. Vol. 133, N 2. P. 461–467. doi: 10.1016/j.jaci.2013.08.016.
DOI: 10.1016/j.jaci.2013.08.016
Gonzalez-Estrada A., Silvers S.K., Klein A., et al. Epidemiology of anaphylaxis at a tertiary care center: A report of 730 cases // Ann Allergy Asthma Immunol. 2017. Vol. 118, N 1. P. 80–85. doi: 10.1016/j.anai.2016.10.025.
DOI: 10.1016/j.anai.2016.10.025
Liew W.K., Chiang W.C., Goh A.E., et al. Paediatric anaphylaxis in a Singaporean children cohort: Changing food allergy triggers over time // Asia Pac Allergy. 2013. Vol. 3, N 1. P. 29–34. doi: 10.5415/apallergy.2013.3.1.29.
DOI: 10.5415/apallergy.2013.3.1.29
Worm M., Moneret-Vautrin A., Scherer K., et al. First European data from the network of severe allergic reactions (NORA) // Allergy. 2014. Vol. 69, N 10. P. 1397–1404. doi: 10.1111/all.12475.
DOI: 10.1111/all.12475
Aun M.V., Blanca M., Garro L.S., et al. Nonsteroidal anti-inflammatory drugs are major causes of drug-induced anaphylaxis // J Allergy Clin Immunol Pract. 2014. Vol. 2, N 4. P. 414–420. doi: 10.1016/j.jaip.2014.03.014.
DOI: 10.1016/j.jaip.2014.03.014
Poziomkowska-Gęsicka I., Kurek M. Clinical manifestations and causes of anaphylaxis. Analysis of 382 Cases from the Anaphylaxis Registry in West Pomerania Province in Poland // Int J Environ Res Public Health. 2020. Vol. 17, N 8. P. 2787. doi: 10.3390/ijerph17082787.
DOI: 10.3390/ijerph17082787
Peng M.M., Jick H. A population-based study of the incidence, cause and severity of anaphylaxis in the United Kingdom // Arch Intern Med. 2004. Vol. 164, N 3. P. 317–319. doi: 10.1001/archinte.164.3.317.
DOI: 10.1001/archinte.164.3.317
Jarez E.J., Cagnani C.E., Sanches-Borges M., et al. Drug induced anaphylaxis in Latin American countries // J Allergy Clin Immunol Pract. 2015. Vol. 3, N 5. P. 780–788. doi: 10.1016/j.jaip.2015.05.012.
DOI: 10.1016/j.jaip.2015.05.012
Doña I., Pérez-Sánchez N., Eguiluz-Gracia I., et al. Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs // Allergy. 2020. Vol. 75, N 3. P. 561–575. doi: 10.1111/all.14032.
DOI: 10.1111/all.14032
Himly M., Jahn-Schmid B., Pittertschatscher K., et al. IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone // J Allergy Clin Immunol. 2003. Vol. 111, N 4. P. 882–888. doi: 10.1067/mai.2003.163.
DOI: 10.1067/mai.2003.163
Torres M.J., Montanez M.I., Ariza A., et al. The role of IgE recognition in allergic reactions to amoxicillin and clavulanic acid // Clin Exp Allergy. 2016. Vol. 46, N 2. P. 264–274. doi: 10.1111/cea.12689.
DOI: 10.1111/cea.12689
Bogas G., Mayorga C., Martín-Serrano Á., et al. Penicillin and cephalosporin cross-reactivity: Role of side chain and synthetic cefadroxil epitopes // Clin Transl Allergy. 2020. Vol. 10, N 1. P. 57. doi: 10.1186/s13601-020-00368-1.
DOI: 10.1186/s13601-020-00368-1
Brazil E., MacNamara A.F. "Not so immediate" hypersensitivity--the danger of biphasic anaphylactic reactions // J Accid Emergency Med. 1998. Vol. 15, N 4. P. 252–253. doi: 10.1136/emj.15.4.252.
DOI: 10.1136/emj.15.4.252
Douglas D.M., Sukenick E., Andrade W.P., Brown J.S. Biphasic systemic anaphylaxis: An inpatient and outpatient study // J Allergy Clin Immunol. 1994. Vol. 93, N 6. P. 977–985. doi: 10.1016/s0091-6749(94)70044-3.
DOI: 10.1016/s0091-6749(94)70044-3
Stark B.J., Sullivan T.J. Biphasic and protracted anaphylaxis // J Allergy Clin Immunol. 1986. Vol. 78, N 1, Pt 1. P. 76–83. doi: 10.1016/0091-6749(86)90117-x.
DOI: 10.1016/0091-6749(86)90117-x
Confino-Cohen R., Goldberg A. Allergen immunotherapy-induced biphasic systemic reactions: Incidence, characteristics, and outcome: A prospective study // Ann Allergy Asthma Immunol. 2010. Vol. 104, N 1. P. 73–78. doi: 10.1016/j.anai.2009.11.001.
DOI: 10.1016/j.anai.2009.11.001
Liu X., Lee S., Lohse C.M., et al. Biphasic reactions in emergency department anaphylaxis patients: A prospective cohort study // J Allergy Clin Immunol Pract. 2020. Vol. 8, N 4. P. 1230–1238. doi: 10.1016/j.jaip.2019.10.027.
DOI: 10.1016/j.jaip.2019.10.027
Kemp S.F., Lockey R.F. Anaphylaxis: A review of causes and mechanisms // J Allergy Clin Immunol. 2002. Vol. 110, N 3. P. 341–348. doi: 10.1067/mai.2002.126811.
DOI: 10.1067/mai.2002.126811
Worm M., Francuzik W., Renaudin J.M., et al. Factors increasing the risk for a severe reaction in anaphylaxis: An analysis of data from the European Anaphylaxis Registry // Allergy. 2018. Vol. 73, N 6. P. 1322–1330. doi: 10.1111/all.13380.
DOI: 10.1111/all.13380
Francuzik W., Kraft M., Hofmeier K., et al. Anaphylaxis in middle-aged patients // Allergol Select. 2021. N 5. P. 133–139. doi: 10.5414/ALX02216E.
DOI: 10.5414/ALX02216E
Sampson H.A., Mendelson L., Rosen J.P. Fatal and near-fatal anaphylactic reactions to food in children and adolescents // N Engl J Med. 1992. Vol. 327, N 6. P. 380–384. doi: 10.1056/NEJM199208063270603.
DOI: 10.1056/NEJM199208063270603
Francuzik W., Nassiri M., Babina M., Worm M. Impact of sex on anaphylaxis severity--data from the anaphylaxis registry // J Allergy Clin Immunol. 2015. Vol. 136, N 5. P. 1425–1426. doi: 10.1016/j.jaci.2015.06.052.
DOI: 10.1016/j.jaci.2015.06.052
Lieberman P., Camargo C.A., Bohlke K., et al. Epidemiology of anaphylaxis: Findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group // Ann Allergy Asthma Immunol. 2006. Vol. 97, N 5. P. 596–602. doi: 10.1016/S1081-1206(10)61086-1.
DOI: 10.1016/S1081-1206(10)61086-1
Van der Klauw M.M., Wilson J.H., Stricker B.H. Drug-associated anaphylaxis: 20 years of reporting in The Netherlands (1974–1994) and review of the literature // Clin Exp Allergy. 1996. Vol. 26, N 12. P. 1355–1363. doi: 10.1046/j.1365-2222.1996.d01-300.
DOI: 10.1046/j.1365-2222.1996.d01-300
Simons F.E., Gu X., Johnston L.M., Simons K.J. Can epinephrine inhalations be substituted for epinephrine injection in children at risk for systemic anaphylaxis? // Pediatrics. 2000. Vol. 106, N 5. P. 1040–1044. doi: 10.1542/peds.106.5.1040.
DOI: 10.1542/peds.106.5.1040
Grabenhenrich L.B., Dölle S., Ruëff F., et al. Epinephrine in severe allergic reactions: The European anaphylaxis register // J Allergy Clin Immunol Pract. 2018. Vol. 6, N 6. P. 1898–1906.e1. doi: 10.1016/j.jaip.2018.02.026.
DOI: 10.1016/j.jaip.2018.02.026
Vitte J., Amadei L., Gouitaa M., et al. Paired acute-baseline serum tryptase levels in perioperative anaphylaxis: An observational study // Allergy. 2019. Vol. 74, N 6. P. 1157–1165. doi: 10.1111/all.13752.
DOI: 10.1111/all.13752
Lyons J.J., Yu X., Hughes J.D., et al. Elevated basal serum tryptase identifies a multisystem disorder associated with increased TPSAB1 copy number // Nature Genetics. 2016. Vol. 48, N 12. P. 1564–1569. doi: 10.1038/ng.3696.
DOI: 10.1038/ng.3696
Valent P., Akin C. Doctor, I Think I. Am suffering from MCAS: Differential diagnosis and separating facts from fiction // J Allergy Clin Immunol. 2019. Vol. 7, N 4. P. 1109–1114. doi: 10.1016/j.jaip.2018.11.045.
DOI: 10.1016/j.jaip.2018.11.045